Volume 7.13 | Apr 5

Pancreatic Cell News 7.13 April 5, 2016
Pancreatic Cell News
     In this issue: Publications | Reviews | Science News | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  PACN on Twitter
New Method Measures the Risk of Type 2 Diabetes in Blood
Researchers have found a new type of biomarker that can predict the risk of type 2 diabetes, by detecting epigenetic changes in specific genes through a simple blood test. [Press release from Lund University discussing online publication in Nature Communications] Press Release | Full Article
Register Now: Webinar on Using iPSCs for Studying Pancreatic Development and Disease
PUBLICATIONS (Ranked by impact factor of the journal)

Hypoxia Reduces ER-to-Golgi Protein Trafficking and Increases Cell Death by Inhibiting the Adaptive Unfolded Protein Response in Mouse Beta Cells
Researchers investigated whether or not hypoxia regulates the unfolded protein response (UPR) in beta cells and the role the adaptive UPR plays during hypoxic stress. [Diabetologia] Abstract

Preadipocyte Factor 1 Induces Pancreatic Ductal Cell Differentiation into Insulin-Producing Cells
Investigators showed that preadipocyte factor 1 induces insulin synthesis and secretion via two independent pathways. [Sci Rep] Full Article

Long-Term Exposure of Pancreatic Beta-Cells to Palmitate Results in SREBP-1C-Dependent Decreases in GLP-1 Receptor Signaling via CREB and AKT and Insulin Secretory Response
Exposure of murine islets, as well as of human and INS-1E beta-cells, to palmitate reduced the ability of exendin-4 to augment insulin mRNA levels, protein content, and release. In addition, palmitate blocked exendin-4-stimulated CREB and AKT phosphorylation, whereas phosphorylation of MEK-1/2 and ERK-1/2 was not altered. [Endocrinology] Abstract | Full Article

TCR Transgenic Mice Reveal the Impact of Type 1 Diabetes Loci on Early and Late Disease Checkpoints
The authors assessed the role of various non-major histocompatibility complex insulin-dependent diabetes diabetes-resistance loci, which have been validated in the non-transgenic setting, on autoimmune diabetes progression in the transgenic setting. [Immunol Cell Biol] Abstract

Pancreatic β-Cell Dysfunction in Diet-Induced Obese Mice: Roles of AMP-Kinase, Protein Kinase Cε, Mitochondrial and Cholesterol Metabolism, and Alterations in Gene Expression
C57BL/6N mice were fed for 8 weeks with a normal chow diet or a high fat diet and stratified as low responders (LDR) and responders (HDR). Freshly isolated islets from ND, LDR and HDR mice were studied ex-vivo for mitochondrial metabolism, AMPK activity and signalling, the expression and activity of key enzymes of energy metabolism, cholesterol synthesis, and mRNA profiling. [PLoS One] Full Article


Identification of Tumorigenic Cells and Therapeutic Targets in Pancreatic Neuroendocrine Tumors
Researchers profiled primary and metastatic tumors from an index patient and demonstrated that MET proto-oncogene activation is important for tumor growth in pancreatic neuroendocrine tumor xenograft models. [Proc Natl Acad Sci USA] Abstract

p120 Catenin Suppresses Basal Epithelial Cell Extrusion in Invasive Pancreatic Neoplasia
The authors identified molecular requirements for early cellular invasion using a premalignant mouse model of pancreatic cancer with conditional knockout of p120 catenin. [Cancer Res] Abstract

Suppression of STAT5b in Pancreatic Cancer Cells Leads to Attenuated Gemcitabine Chemoresistance, Adhesion and Invasion
The authors examined the expression and role of signal transducers and activators of transcription 5 (STAT5) in human pancreatic cancer cell lines. Expressions of STAT5b mRNA and protein were detected in eight kinds of pancreatic cancer cells. [Oncol Rep] Full Article

Request Sample: ReLeSR™, Easy Passaging Through Selective Detachment of hPSCs
Evaluation and Management of Pancreatic Lesions in Patients with von Hippel-Lindau Disease
The authors characterize the types of pancreatic lesions associated with von Hippel–Lindau disease and their natural history, to identify particular lesions that necessitate treatment, and to define what forms of treatment should be undertaken. [Nat Rev Clin Oncol] Abstract

Visit our reviews page to see a complete list of reviews in the pancreatic cell research field.
Salmonella-Based Oral Vaccine a Promising Therapy for Preventing Type 1 Diabetes
A combined vaccine therapy including live Salmonella is a safe and effective way to prevent diabetes in mice and may point to future human therapies. [Press release from the Endocrine Society (Newswise, Inc.) discussing research presented at the 98th Annual Meeting & Exposition of the Endocrine Society (ENDO), Boston] Press Release

Saxenda® (Liraglutide [rDNA Origin] injection) Demonstrated Significant Improvements in Cardiometabolic Risk Factors over Three Years Compared with Placebo
New data from the three-year part of the Phase IIIa SCALE™ Obesity and Pre-diabetes trial were presented. The three-year part of the trial data demonstrated that 160 weeks of treatment with Saxenda® in combination with a reduced-calorie diet and increased physical activity resulted in significant improvements in cardiometabolic risk factors compared with placebo. [Press release from Novo Nordisk Inc. discussing research presented at the 98th Annual Meeting & Exposition of the Endocrine Society (ENDO), Boston] Press Release

New Procedure Could Improve Success Rate of Cell Transplant to Cure Type 1 Diabetes
New research suggests pretreating cells with a peptide hormone may improve the success rate of pancreatic islet cell transplants, a procedure that holds great promise for curing Type 1 diabetes. [Press release from the Endocrine Society (EurekAlert!) discussing research presented at the 98th Annual Meeting & Exposition of the Endocrine Society (ENDO), Boston] Press Release

Ask The Expert: Need help differentiating hPSCs to pancreatic progenitor cells? Join the Q&A session.
Baxter Family Gifts $1.2 Million to Endocrine Society to Recognize Innovation and Entrepreneurship in Endocrinology
With a $1.2 million gift from the family of Dr. John D. Baxter, the Endocrine Society established the John D. Baxter Prize for Entrepreneurship to recognize scientists and clinicians who have demonstrated innovation and entrepreneurship by furthering the translation of endocrine research into patient care. [Endocrine Society] Press Release

Intrexon Forms Collaboration to Develop Treatment for Type 1 Diabetes
Intrexon Corporation announced the formation of Intrexon T1D Partners, LLC, a joint venture with a select group of external investors led by White Rock Capital Partners, LP, to develop ActoBiotics® based antigen-specific immunotherapy to treat type 1 diabetes in humans. [Intrexon Corporation] Press Release

VUMC and Celgene Corporation Enter into Research Agreement to Accelerate Development of Next-Generation Therapeutics
Vanderbilt University Medical Center (VUMC) has entered into a strategic research agreement with Celgene Corporation. This collaboration will leverage BioVU, a DNA database linked to de-identified health information that includes 2.5 million clinical records and 215,000 genetic samples. [Vanderbilt University Medical Center] Press Release
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
NEW Mouse Development, Stem Cells & Cancer
July 8-28, 2016
Cold Spring Harbor, United States

Visit our events page to see a complete list of events in the pancreatic cell community.
NEW Group Leader – Stem Cell Biology, Pancreatic Cancer and Bioengineering (University of Copenhagen)

NEW PhD Studentship – Regulation of Metabolism (University of Wuerzburg)

Postdoctoral Fellow – Diabetes Induced Neural Tube Defects (UMB School of Medicine)

Postdoctoral Fellow – Pancrease Preconditioning (Centre Européen d’Etude du Diabète)

Postdoctoral Fellow – Pancreatic Zinc Transporter as Therapeutic Target (Johns Hopkins School of Medicine)

Research Scientist – Various Fields (King Abdullah International Medical Research Center)

Postdoctoral Fellowship – Pancreatic Cancer (Fred Hutchinson Cancer Research Center)

Master Studentship – Exercise and Diabetes (Swansea University)

Postdoctoral Research Fellowship – Pancreatic Cancer Biology (Fred Hutchinson Cancer Research Center)

Postdoctoral Research Fellowship – Surgical Oncology in Pancreatic Cancer (University of Nebraska Medical Center)

Postdoctoral Research Fellowship – Pancreatic Progenitors in Development (Johns Hopkins University Institute of Genetic Medicine)

Postdoctoral Fellowship – Metabolism and Cancer (Monash University)

Postdoctoral Fellowship – Mechanisms of Atherosclerosis, Diabetes and Obesity (Washington University School of Medicine)

Postdoctoral Fellowship – Neural Mechanisms of Diabetes (Albert Einstein College of Medicine)

Faculty Position – Metabolic Disease Research (Lewis Katz School of Medicine)

Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Have we missed an important article or publication in Pancreatic Cell News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about Pancreatic Cell News: Archives | Events | Contact Us